FIRST INNOVATIVE MEDICINES INITIATIVE PROJECTS UNDER WAY
June 1st, 2009
BY KEITH NUTHALL
PHARMACEUTICAL researchers are preparing for the first 15 projects funded through the European Union's (EU) Innovative Medicines Initiative. These will share Euro 246 million, with Euro 110 million from the EU's seventh framework programme (FP7) and the pharmaceutical sector providing the remaining Euro 136 million through in kind contributions, such as personnel and facilities. Topics covered will include non-genotoxic carcinogenesis; silico toxicity; translational safety biomarkers; monitoring medicine benefit/risk; islet cells; surrogate ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.